Stromal keratitis
disease diseaseOn this page
Summary
Stromal keratitis (MONDO:0015291) is a disease and 1 clinical trial. A subtype of herpes simplex virus keratitis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: 1-9 / 100 000 (Worldwide) [Orphanet-validated]
- Phenotypes (HPO): 17
- Clinical trials: 1
Clinical features
Epidemiology
Prevalence records
2 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Point prevalence | 1-9 / 100 000 | 4.2091 | Worldwide | Validated |
| Annual incidence | 1-9 / 100 000 | 5.4 | France | Validated |
Signs & symptoms
Clinical features (HPO)
17 HPO clinical features (Orphanet curated; top 17 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0007663 | Reduced visual acuity | Very frequent (80-99%) |
| HP:0007765 | Deep anterior chamber | Very frequent (80-99%) |
| HP:0012040 | Corneal stromal edema | Very frequent (80-99%) |
| HP:0012108 | Open angle glaucoma | Very frequent (80-99%) |
| HP:0000622 | Blurred vision | Frequent (30-79%) |
| HP:0007812 | Herpetiform corneal ulceration | Frequent (30-79%) |
| HP:0007906 | Ocular hypertension | Frequent (30-79%) |
| HP:0009926 | Epiphora | Frequent (30-79%) |
| HP:0012039 | Descemet Membrane Folds | Frequent (30-79%) |
| HP:0012155 | Decreased corneal sensation | Frequent (30-79%) |
| HP:0030953 | Conjunctival hyperemia | Frequent (30-79%) |
| HP:0031448 | Herpetiform vesicles | Frequent (30-79%) |
| HP:0100583 | Corneal perforation | Frequent (30-79%) |
| HP:0000491 | Keratitis | Occasional (5-29%) |
| HP:0000618 | Blindness | Occasional (5-29%) |
| HP:0011134 | Low-grade fever | Occasional (5-29%) |
| HP:0033834 | Malaise | Occasional (5-29%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | stromal keratitis |
| Mondo ID | MONDO:0015291 |
| Orphanet | 137599 |
| ICD-11 | 1665288755 |
| UMLS | C1318020 |
| MedGen | 727306 |
| GARD | 0019879 |
| Is cancer (heuristic) | no |
Disease family
This is a subtype of herpes simplex virus keratitis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious disease › viral infectious disease › primary viral infectious disease › Herpesviridae infectious disease › herpes simplex infectious disease › herpes simplex virus keratitis › stromal keratitis
Related subtypes (1): endotheliitis
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 1.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT05156151 | Not specified | UNKNOWN | Stromal Lenticule Implantation for Management of Herpetic Stromal Keratitis |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.